Literature DB >> 20159215

The Beliefs about Emotions Scale: validity, reliability and sensitivity to change.

Katharine A Rimes1, Trudie Chalder.   

Abstract

OBJECTIVE: Beliefs about the unacceptability of experiencing or expressing negative emotions have been noted in individuals with a range of problems, including chronic fatigue syndrome (CFS), irritable bowel syndrome, somatization disorder, depression, eating disorders, social phobia, posttraumatic stress disorder, and borderline personality disorder. These beliefs are likely to have implications for emotion regulation and processing, and are addressed explicitly or implicitly within many therapies including cognitive behavior therapy (CBT), mindfulness-based cognitive therapy (MBCT), and Acceptance and Commitment Therapy (ACT). This article describes the development, validation, and internal reliability of the Beliefs about Emotions Scale (BES), a self-report questionnaire to assess such beliefs.
METHODS: The new scale was completed by people with CFS (n=121) and healthy controls (n=73). Twenty-two individuals with CFS completed the scale before and after CBT.
RESULTS: People with CFS had significantly higher scores on this new questionnaire than healthy controls. Principal components analysis identified one factor, and the scale had high internal consistency (0.91). Scores on the BES were most highly correlated with a measure of negative perfectionism (r=0.59) and also showed significant correlations with measures of dysfunctional attitudes, self-sacrifice, depression, anxiety, and fatigue. When completed before and after CBT for CFS, the questionnaire was sufficiently sensitive to detect a significant reduction in endorsement of unhelpful beliefs about emotions.
CONCLUSION: The new Beliefs about Emotions Scale showed good internal reliability, validity and sensitivity to change. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20159215     DOI: 10.1016/j.jpsychores.2009.09.014

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  22 in total

1.  Same, Same But Different? Cognitive Behavioural Treatment Approaches for Paediatric CFS/ME and Depression.

Authors:  M E Loades; T Chalder
Journal:  Behav Cogn Psychother       Date:  2017-03-09

Review 2.  Dimensions of emotion dysregulation in anorexia nervosa and bulimia nervosa: A conceptual review of the empirical literature.

Authors:  Jason M Lavender; Stephen A Wonderlich; Scott G Engel; Kathryn H Gordon; Walter H Kaye; James E Mitchell
Journal:  Clin Psychol Rev       Date:  2015-06-06

3.  Cross-Cultural Comparison of the Contexts Associated with Emotional Outbursts.

Authors:  Justin Cheuk Yin Chung; Rosane Lowenthal; Carmel Mevorach; Cristiane Silvestre Paula; Maria Cristina Triguero Veloz Teixeira; Kate Anne Woodcock
Journal:  J Autism Dev Disord       Date:  2022-08-19

4.  Cognitive-behavioural therapy compared with standardised medical care for adults with dissociative non-epileptic seizures: the CODES RCT.

Authors:  Laura H Goldstein; Emily J Robinson; Izabela Pilecka; Iain Perdue; Iris Mosweu; Julie Read; Harriet Jordan; Matthew Wilkinson; Gregg Rawlings; Sarah J Feehan; Hannah Callaghan; Elana Day; James Purnell; Maria Baldellou Lopez; Alice Brockington; Christine Burness; Norman A Poole; Carole Eastwood; Michele Moore; John Dc Mellers; Jon Stone; Alan Carson; Nick Medford; Markus Reuber; Paul McCrone; Joanna Murray; Mark P Richardson; Sabine Landau; Trudie Chalder
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

5.  Investigating the role of beliefs about emotions, emotional suppression and distress within a pain management programme for fibromyalgia.

Authors:  Hannah M Bowers; Tamar Pincus; Gareth Jones; Abigail L Wroe
Journal:  Br J Pain       Date:  2019-01-09

6.  Perfectionism and beliefs about emotions in adolescents with chronic fatigue syndrome and their parents: a preliminary investigation in a case control study nested within a cohort.

Authors:  Maria E Loades; Katharine A Rimes; Kate Lievesley; Sheila Ali; Trudie Chalder
Journal:  Psychol Health       Date:  2019-03-01

7.  COgnitive behavioural therapy vs standardised medical care for adults with Dissociative non-Epileptic Seizures (CODES): a multicentre randomised controlled trial protocol.

Authors:  Laura H Goldstein; John D C Mellers; Sabine Landau; Jon Stone; Alan Carson; Nick Medford; Markus Reuber; Mark Richardson; Paul McCrone; Joanna Murray; Trudie Chalder
Journal:  BMC Neurol       Date:  2015-06-27       Impact factor: 2.474

8.  Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised controlled trial of clinical-effectiveness and cost-effectiveness of therapist delivered cognitive behavioural therapy and web-based self-management in irritable bowel syndrome in adults.

Authors:  Hazel Everitt; Sabine Landau; Paul Little; Felicity L Bishop; Paul McCrone; Gilly O'Reilly; Nicholas Coleman; Robert Logan; Trudie Chalder; Rona Moss-Morris
Journal:  BMJ Open       Date:  2015-07-15       Impact factor: 2.692

9.  Emotional and social mind training: a randomised controlled trial of a new group-based treatment for bulimia nervosa.

Authors:  Anna Lavender; Helen Startup; Ulrike Naumann; Nelum Samarawickrema; Hannah Dejong; Martha Kenyon; Frederique van den Eynde; Ulrike Schmidt
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  The MOSAIC study - comparison of the Maudsley Model of Treatment for Adults with Anorexia Nervosa (MANTRA) with Specialist Supportive Clinical Management (SSCM) in outpatients with anorexia nervosa or eating disorder not otherwise specified, anorexia nervosa type: study protocol for a randomized controlled trial.

Authors:  Ulrike Schmidt; Beth Renwick; Anna Lose; Martha Kenyon; Hannah Dejong; Hannah Broadbent; Rachel Loomes; Charlotte Watson; Shreena Ghelani; Lucy Serpell; Lorna Richards; Eric Johnson-Sabine; Nicky Boughton; Linette Whitehead; Jennifer Beecham; Janet Treasure; Sabine Landau
Journal:  Trials       Date:  2013-05-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.